Literature DB >> 10394988

The prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in young women.

K Gupta1, T M Hooton, C L Wobbe, W E Stamm.   

Abstract

Four hundred and fifty-two urine isolates from women with acute uncomplicated cystitis and a positive urine culture presenting to a sexually transmitted disease clinic were collected during 1989-1991, and 213 specimens were collected over 1995-1997. The predominant species was Escherichia coli, representing 68% of the isolates; others included Staphylococcus saprophyticus (8%), Group B streptococci (7%), Proteus spp. (6%), Klebsiella spp. (4%) and Enterococcus spp.(3%). More than 10% of the E. coli isolates were resistant to ampicillin, cephalothin, tetracycline and trimethoprim sulfamethoxazole (TMP SMX ) during both study periods, with the greatest increase in resistance to ampicillin and TMP/SMX between the two periods. Six hundred and four urinary tract infection isolates, including 83% E. coli, 7% S. saprophyticus, 3%, Klebsiella spp. 2% Proteus spp., 2% enterococci, 1% Enterobacter spp. and 2% other organisms, were collected from women with acute cystitis attending a university student health service during 1995. Among E. coli isolates, 25% were resistant to ampicillin, 24% to tetracycline and 11%, to TMP SMX. Resistance to fluoroquinolones was essentially absent among gram-negative pathogens. Continued evaluation of susceptibility patterns of pathogens causing acute uncomplicated cystitis to traditional as well as new antimicrobials in well defined populations is necessary to ascertain the optimal empiric therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10394988     DOI: 10.1016/s0924-8579(99)00035-7

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  24 in total

1.  An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999-2009.

Authors:  I M Cullen; R P Manecksha; E McCullagh; S Ahmad; F O'Kelly; R Flynn; T E D McDermott; P Murphy; R Grainger; J P Fennell; J A Thornhill
Journal:  Ir J Med Sci       Date:  2012-06-06       Impact factor: 1.568

2.  Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.

Authors:  A Sotto; C M De Boever ; P Fabbro-Peray; A Gouby; D Sirot; J Jourdan
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

3.  Evidence of Sharing of Klebsiella pneumoniae Strains between Healthy Companion Animals and Cohabiting Humans.

Authors:  Cátia Marques; Adriana Belas; Catarina Aboim; Patrícia Cavaco-Silva; Graça Trigueiro; Luís Telo Gama; Constança Pomba
Journal:  J Clin Microbiol       Date:  2019-05-24       Impact factor: 5.948

4.  Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000.

Authors:  D F Sahm; C Thornsberry; D C Mayfield; M E Jones; J A Karlowsky
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

5.  Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli.

Authors:  Lionel Durant; Arnaud Metais; Coralie Soulama-Mouze; Jean-Marie Genevard; Xavier Nassif; Sonia Escaich
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

6.  Partial Purification and Characterization of a Bacteriocin DT24 Produced by Probiotic Vaginal Lactobacillus brevis DT24 and Determination of its Anti-Uropathogenic Escherichia coli Potential.

Authors:  Disha Trivedi; Prasant Kumar Jena; Jignesh Kumar Patel; Sriram Seshadri
Journal:  Probiotics Antimicrob Proteins       Date:  2013-06       Impact factor: 4.609

7.  Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study.

Authors:  James A Karlowsky; Philippe R S Lagacé-Wiens; Patricia J Simner; Melanie R DeCorby; Heather J Adam; Andrew Walkty; Daryl J Hoban; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

8.  Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States.

Authors:  James A Karlowsky; Laurie J Kelly; Clyde Thornsberry; Mark E Jones; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

9.  Synchrotron X-ray fluorescence microscopy of gallium in bladder tissue following gallium maltolate administration during urinary tract infection.

Authors:  Katherine R Ball; Francesca Sampieri; Manuel Chirino; Don L Hamilton; Robert I R Blyth; Tsun-Kong Sham; Patricia M Dowling; Julie Thompson
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

Review 10.  Current issues in the management of urinary tract infections: extended-release ciprofloxacin as a novel treatment option.

Authors:  Joseph M Blondeau
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.